Healthtech Startups

Order-made Medical Research Inc. (OMR) develops antibody drug discovery technologies, including its LIMAXYS platform for generating antibodies against multi-pass transmembrane targets, plus the INTAB and MUTAB platforms for internalizing and disease-specific mutation antibodies. The company aims to create new antibody-based therapies for hard-to-treat cancers, autoimmune diseases, and neurodegenerative disorders.

1 investor

ONCALL operates a home medical care support service in Japan, providing night and holiday house-call teams plus an online "Connect" team that supports clinical decisions and links medical institutions and multidisciplinary staff nationwide. It aims to expand young physicians' involvement in home care and improve the quality and supply of home-based medical care, particularly end-of-life care.

1 investor

On the Right Track provides a patented hookless cubicle curtain track system, recyclable and textile curtains, in-person curtain changeout services, and a cloud-based QR-code tracking app for hospitals and healthcare facilities. Its products aim to reduce hospital-associated infections and improve compliance and operational efficiency for regional hospitals, healthcare networks, surgery centers, and similar facilities.

1 investor

Ona provides an AI phone agent for healthcare clinics and practices that answers calls 24/7, books appointments into live calendars, captures patient intake data into charts, and routes complex calls to humans. It serves solo to enterprise medical practices across primary care, behavioral health, physical therapy, and specialty care.

1 investor

Oncobox provides genetic profiling of tumor samples to help oncologists select the most likely effective drug from existing targeted cancer therapies for individual patients with advanced cancer. The analysis examines tumor DNA, RNA, and molecular pathways to identify the most relevant drug targets and generates a clinical report recommending which treatments are most likely to work.

1 investor

Oncoclínicas operates a network of over 140 units — clinics, genomics and pathology laboratories, and integrated cancer treatment centers — across 40 Brazilian cities. It provides cancer diagnosis and treatment services for patients in Brazil.

1 investor

Oncodea is a cancer research company developing early cancer detection and monitoring methods intended to be fast, affordable, and accessible to a broad population. It positions itself as more than a research lab, focused on making cancer testing inexpensive enough for regular use.

1 investor

OncoForma develops a functional precision oncology platform that tests patient-derived tumor organoids against comprehensive drug panels to predict treatment efficacy before therapy begins. The company serves oncologists and cancer patients in the global oncology market, operating from Saskatchewan with a pathway to scale from fee-for-service testing to AI-enabled predictive medicine.

1 investor

OncoInsight develops off-the-shelf natural killer (NK) cell therapy product candidates aimed at treating cancer patients. The company operates in the biotech and cell therapy space.

1 investor

Oncoliq develops early cancer detection technology that combines molecular biology and machine learning to offer a non-toxic, non-invasive, and low-cost diagnostic approach. The company operates in the cancer diagnostics field.

1 investor

A clinical research organization that conducts clinical trials to provide innovative therapies to patients in specific medical conditions at no additional cost.

1 investor

Oncology Ventures is a venture capital firm that invests in healthcare data companies addressing problems in U.S. cancer care, from early detection and precision diagnostics to patient navigation, treatment optimization, and survivorship. It backs founders building data-driven and AI-powered technologies across the oncology system.

1 investor

OncoLux develops an optical theranostic system that gives surgeons intraoperative enhanced visualization of residual cancer and combines it with optical photodynamic therapy to treat remaining tumor tissue during surgery. The technology targets cancer surgery patients and clinicians in the medical device field.

1 investor

OncoNano Medicine develops a proprietary nanotechnology platform for cancer therapeutics that targets the acidic tumor microenvironment to improve drug delivery to tumors. The company serves oncology patients and builds a pipeline of therapies designed for more precise cancer treatment.

1 investor

1 investor

OncoRevive develops a multiomics blood test combining nanotechnology, cancer biology, and AI to detect and monitor cancer in less than 2 hours at a fraction of current costs. The test is designed for healthcare providers, hospitals, and pathology labs seeking rapid, comprehensive same-day cancer diagnostics.

1 investor

OncoSenX is a late-stage pre-clinical cancer therapeutics company developing treatments that target solid tumors based on transcriptional activity. Its system pairs a patented Proteo-Lipid Vehicle (PLV) delivery agent with plasmid DNA payloads that induce apoptosis in cancer cells while sparing adjacent cells.

1 investor

Oncostellae is a biotech company developing novel JAK inhibitors for the treatment of inflammatory bowel disease and cancer, with a focus on local, gut-restricted therapies that minimize systemic toxicity.

1 investor

OncoSwab develops a nasal swab-based sampling platform that captures airway-derived genetic material to detect ctDNA and cancer-associated biomarkers at the origin of lung cancer, complementing blood-based liquid biopsy. It is offered as a Research Use Only tool for researchers running lung cancer biomarker, longitudinal, and multi-site studies while clinical validation is underway.

1 investor

Oncosyne develops functional biology tools and preclinical models for cancer drug development and patient stratification, serving oncology drug developers and precision medicine researchers.

1 investor

OncoSynergy is a clinical-stage immuno-oncology company developing monoclonal antibody therapeutics, including a pan-CD29 antibody and a PD1-targeting antibody. It operates in the biotech and cancer drug development space.

1 investor

OncRef provides structured oncology intelligence—a database and query layer aggregating clinical trials, drugs, mechanisms, approvals, guidelines, and key opinion leaders—for oncology professionals and life-science teams seeking current, unified information across the cancer field.

1 investor

Oncura provides veterinary ultrasound systems designed for use by general practice teams, with real-time remote guidance from sonographers and internal medicine specialists. The platform includes a portable ultrasound device and secure telehealth portal to enable quick diagnosis of common conditions without requiring on-site specialist expertise.

1 investor

Ondal Medical Systems manufactures suspension arm systems designed for safe and ergonomic handling of medical devices in clinical environments. The company serves medical technology providers and healthcare facilities globally with suspension solutions that improve workflow efficiency.

1 investor